Skip to content

CIK 0001741830

KRON Kronos Bio, Inc.

Insider trading from SEC Form 4. Last filing Jun 20, 2025.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
12
with a Form 4 at this company

Signals

Open-market buys and sells at Kronos Bio, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
30WeakDeborah Knobelman
President & Interim CEO
sell
$22k
24,838 shares
-15%-

Transactions

The last 59 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Jun 20, 2025Arie Belldegrun
director
UTender of shares
Common Stockindirect: By Vida Ventures, LLC
-2,765,314$0.57$1.6M0Jun 20, 2025
Jun 20, 2025Roger D Dansey
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-68,000$0.00$00Jun 20, 2025
Jun 20, 2025Roshawn A. Blunt
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-41,200$0.00$00Jun 20, 2025
Jun 20, 2025Deborah Knobelman
President & Interim CEO
UTender of shares
Common Stock
-139,422$0.57$79k0Jun 20, 2025
Jun 20, 2025Joshua A Kazam
director
UTender of shares
Common Stock
-94,481$0.57$54k0Jun 20, 2025
Jun 20, 2025Katherine Stultz V
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-68,000$0.00$00Jun 20, 2025
Jun 20, 2025Taiyin Yang
director
UTender of shares
Common Stock
-11,333$0.57$6,4600Jun 20, 2025
Jun 20, 2025David M Tanen
director
UTender of shares
Common Stock
-363,428$0.57$207k0Jun 20, 2025
Jun 20, 2025Elena Ridloff
director
UTender of shares
Common Stock
-25,296$0.57$14k0Jun 20, 2025
Jun 20, 2025Norbert W Bischofberger
director, owner
UTender of shares
Common Stockindirect: See Footnote
-10,802,138$0.57$6.2M0Jun 20, 2025
Jun 20, 2025Taiyin Yang
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-41,200$0.00$00Jun 20, 2025
Jun 20, 2025Katherine Stultz V
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-7,079$0.00$00Jun 20, 2025
Jun 20, 2025Norbert W Bischofberger
director, owner
UTender of shares
Common Stockindirect: See Footnote
-263,750$0.57$150k0Jun 20, 2025
Jun 20, 2025Joshua A Kazam
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-20,600$0.00$00Jun 20, 2025
Jun 20, 2025David M Tanen
director
UTender of shares
Common Stockindirect: See Footnote
-471,230$0.57$269k0Jun 20, 2025
Jun 20, 2025Deborah Knobelman
President & Interim CEO
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-246,390$0.00$00Jun 20, 2025
Jun 20, 2025Elena Ridloff
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-25,879$0.00$00Jun 20, 2025
Jun 20, 2025Roger D Dansey
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-5,868$0.00$00Jun 20, 2025
Jun 20, 2025Roshawn A. Blunt
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-34,000$0.00$00Jun 20, 2025
Jun 20, 2025Arie Belldegrun
director
UTender of shares
Common Stockindirect: By Bellco Legacy II Trust
-679,575$0.57$387k0Jun 20, 2025
Jun 20, 2025Roshawn A. Blunt
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-34,000$0.00$00Jun 20, 2025
Jun 20, 2025David M Tanen
director
UTender of shares
Common Stockindirect: By Son
-26,375$0.57$15k0Jun 20, 2025
Jun 20, 2025Norbert W Bischofberger
director, owner
UTender of shares
Common Stockindirect: See Footnote
-263,750$0.57$150k0Jun 20, 2025
Jun 20, 2025Taiyin Yang
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-5,150$0.00$00Jun 20, 2025
Jun 20, 2025Elena Ridloff
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-26,871$0.00$00Jun 20, 2025
Jun 20, 2025Katherine Stultz V
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-34,000$0.00$00Jun 20, 2025
Jun 20, 2025Arie Belldegrun
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-20,600$0.00$00Jun 20, 2025
Jun 20, 2025Roger D Dansey
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-34,000$0.00$00Jun 20, 2025
Jun 20, 2025Joshua A Kazam
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-34,000$0.00$00Jun 20, 2025
Jun 20, 2025Taiyin Yang
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-17,000$0.00$00Jun 20, 2025
Jun 20, 2025Norbert W Bischofberger
director, owner
UTender of shares
Common Stockindirect: See Footnote
-263,750$0.57$150k0Jun 20, 2025
Jun 20, 2025David M Tanen
director
UTender of shares
Common Stockindirect: By Son
-26,375$0.57$15k0Jun 20, 2025
Jun 20, 2025Roshawn A. Blunt
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-34,000$0.00$00Jun 20, 2025
Jun 20, 2025Elena Ridloff
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-15,450$0.00$00Jun 20, 2025
Jun 20, 2025Arie Belldegrun
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-34,000$0.00$00Jun 20, 2025
Jun 20, 2025Joshua A Kazam
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-34,000$0.00$00Jun 20, 2025
Jun 20, 2025Arie Belldegrun
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-34,000$0.00$00Jun 20, 2025
Jun 20, 2025Taiyin Yang
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-34,000$0.00$00Jun 20, 2025
Jun 20, 2025Elena Ridloff
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-34,000$0.00$00Jun 20, 2025
Jun 20, 2025Norbert W Bischofberger
director, owner
UTender of shares
Common Stockindirect: See Footnote
-263,750$0.57$150k0Jun 20, 2025
Jun 20, 2025Joshua A Kazam
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-34,000$0.00$00Jun 20, 2025
Jun 20, 2025David M Tanen
director
UTender of shares
Common Stockindirect: By Daughter
-26,375$0.57$15k0Jun 20, 2025
Jun 20, 2025Elena Ridloff
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-17,000$0.00$00Jun 20, 2025
Jun 20, 2025Norbert W Bischofberger
director, owner
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-297,186$0.00$00Jun 20, 2025
Jun 20, 2025David M Tanen
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-85,608$0.00$00Jun 20, 2025
Jun 20, 2025Taiyin Yang
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-34,000$0.00$00Jun 20, 2025
Jun 20, 2025Arie Belldegrun
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-34,000$0.00$00Jun 20, 2025
Jun 20, 2025David M Tanen
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-19,892$0.00$00Jun 20, 2025
Jun 20, 2025Norbert W Bischofberger
director, owner
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-400,000$0.00$00Jun 20, 2025
Jun 20, 2025Elena Ridloff
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-17,000$0.00$00Jun 20, 2025
Jun 20, 2025David M Tanen
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-20,600$0.00$00Jun 20, 2025
Jun 20, 2025Norbert W Bischofberger
director, owner
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-570,868$0.00$00Jun 20, 2025
Jun 20, 2025David M Tanen
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-34,000$0.00$00Jun 20, 2025
Jun 20, 2025Norbert W Bischofberger
director, owner
DDisposition to issuer
Employee Stock Option (Right to Buy)derivative
-699,800$0.00$00Jun 20, 2025
Jun 20, 2025David M Tanen
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-34,000$0.00$00Jun 20, 2025
Jun 20, 2025David M Tanen
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-34,000$0.00$00Jun 20, 2025
Jun 5, 2025Deborah Knobelman
President & Interim CEO
SOpen-market sale
Common Stock
-24,838$0.87$22k139,422Jun 6, 2025
Oct 15, 2024Allison Frisbee
Chief Administrative Officer
AGrant or award
Employee Stock Option (Right to Buy)derivative
+72,900$0.00$072,900Oct 15, 2024
Oct 15, 2024Charles Y Lin
Chief Scientific Officer
AGrant or award
Employee Stock Option (Right to Buy)derivative
+72,900$0.00$072,900Oct 15, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

KRON insider trading: Kronos Bio, Inc. | InsiderTell